Free-standing carbon membranes that are a millionth of a millimetre thin: these are a special research field of Professor Dr. Armin Gölzhäuser from Bielefeld University and his research group. The nanomembranes can serve as ultrafine filters and as a protective layer. The Bielefeld physicists have registered several patents for manufacturing such molecular foils.
Technology and Innovation 19.1 zeroes in on innovation and entrepreneurship, with a special focus on what universities are currently doing to foster growth in those areas both for their success and the success of the communities and regions to which they are connected. Novel educational programs, innovation-driving business accelerators, and ingenious makerspaces that allow users to manufacture their own objects are among the tools being employed by universities to support the entrepreneurial activities so crucial for our economy and our nation.
Biofilms are slimy, glue-like membranes that are produced by microbes in order to colonize surfaces. They protect microbes from the body's immune system and increase their resistance to antibiotics. Biofilms represent one of the biggest threats to patients in hospital settings. But there is good news -- Canadian scientists have developed a novel enzyme technology that prevents the formation of biofilms and can also break them down.
A new study found state medical boards ask physicians much more extensive and intrusive questions about mental health conditions than for physical health conditions. Despite national concern about physician suicide and well-being, research shows that even if physicians struggle with depression, they are reluctant to disclose and seek treatment because it could have serious consequences when they apply for their medical license.
A new paper co-authored by Columbia University Mailman School of Public Health's Bhaven Sampat, PhD, shows that 30 percent of all NIH-funded grants produce research that is cited by a private-sector patent. The publicly-funded research creates knowledge that links to private companies' efforts to develop drugs, medical devices, and other patented biomedical products.
Article shows that publicly-funded research creates knowledge that links to private companies' efforts to develop drugs, medical devices, and other patented biomedical products.
Research grants issued by the National Institutes of Health (NIH) contribute to a significant number of private-sector patents in biomedicine, according to a new study co-authored by an MIT professor. The study, published in the journal Science, examines 27 years of data and finds that 31 percent of NIH grants, which are publicly funded, produce articles that are later cited by patents in the biomedical sector.
As the new administration considers the future direction of the Food and Drug Administration, a group of leading researchers has created a Blueprint for Transparency at the agency to advance the development of safe and effective new products.
When seed funding for start-up companies comes from the universities where the technologies have been developed, benefits go well beyond the money necessary to conduct business. Additional benefits for the institution and community include expanded funding opportunities, hiring and retention of top entrepreneurial faculty, goal setting, entrepreneur development, economic development, and university engagement.
Research reveals likelihood of finding and identifying Mary Jane Kelly -- and using DNA to determine her true identity.